• 의료법학
• /
• 제10권2호
• /
• pp.455-492
• /
• 2009

(Background) Recent biotechnological breakthroughs are shedding new lights on various ethical and legal issues about human biological material. Since Rudolph Virchow, a German pathologist, had founded the medical discipline of cellular pathology, issues centering around human biological materials began to draw attention. The issues involving human biological materials were revisited with more attention along with series concerns when the human genome map was finally completed. Recently, with researches on human genes and bioengineering reaping enormous commercial values in the form of material patent, such changes require a society to reassess the present and future status of human tissue within the legal system. This in turn gave rise to a heated debate over how to protect the rights of material donors: property rule vs. no property rule. (Debate and Cases) Property rule recognizes the donors' property rights on human biological materials. Thus, donors can claim real action if there were any bleach of informed consent or a donation contract. Donors can also claim damages to the responsible party when there is an infringement of property rights. Some even uphold the concept of material patents overtaking. From the viewpoint of no property rule, human biological materials are objects separated from donors. Thus, a recipient or a third party will be held liable if there were any infringement of donor's human rights. Human biological materials should not be commercially traded and a patent based on a human biological materials research does not belong to the donor of the tissues used during the course of research. In the US, two courts, Moore v. Regents of the University of California, and Greenberg v. Miami Children's Hospital Research Institute, Inc., have already decided that research participants retain no ownership of the biological specimens they contribute to medical research. Significantly, both Moore and Greenberg cases found that the researcher had parted with all ownership rights in the tissue samples when they donated them to the institutions, even though there was no provision in the informed consent forms stating either that the participants donated their tissue or waived their rights to ownership of the tissue. These rulings were led to huge controversy over property rights on human tissues. This research supports no property rule on the ground that it can protect the human dignity and prevent humans from objectification and commercialization. Human biological materials are already parted from human bodies and should be treated differently from the engineering and researches of those materials. Donors do not retain any ownership. (Suggestions) No property rule requires a legal breakthrough in the US in terms of donors' rights protection due to the absence of punitive damages provisions. The Donor rights issue on human biological material can be addressed through prospective legislation or tax policies, price control over patent products, and wider coverage of medical insurance. (Conclusions) Amid growing awareness over commercial values of human biological materials, no property rule should be adopted in order to protect human dignity but not without revamping legal provisions. The donors' rights issue in material patents requires prospective legislation based on current uncertainties. Also should be sought are solutions in the social context and all these discussions should be based on sound medical ethics of both medical staffs and researchers.

• 한국중재학회지:중재연구
• /
• 제32권2호
• /
• pp.85-114
• /
• 2022

When human rights disputes are related to the cross-border investments treaties, the investment arbitral tribunals are confronted with the question of how to adjudicate connected human rights violations. The traditional structure restricts arbitration proceedings to the parties named within an investment treaty, i.e., Investor-Claimant and State-Respondent. If human rights issues occur, States must act as proxies for citizens with human rights claims. This effectively excludes individuals or groups with human rights concerns and contradicts the premise of international human rights law that seeks to empower human rights-holders to pursue claims directly and on an international stage. The methods for intorducing human rights issues in the context of investment arbitration proceedings are suggested as follows: First, human rights arguments can be introduced into ISDS by the usual initiator of investment disputes: the investor as the complainant. Especially, if the jurisdictional and applicable law clauses of the respective international investment agreements are sufficiently broad to include human rights violations, adjudicating a pure human rights claim could be possible. Second, the host state may rely on human rights argumentation as a respondent of an investor claim. Human rights have played a role as a justification for state measures undertaken to comply with human rights laws. Third, third party interventions by NGOs and civil society groups as amici curiae may act as advocates for affected populations or communities in response to the reluctance of governments to introduce their own human rights duties into the investment dispute. Finally, arbitrators have also referred to human rights ex officio, i.e., without having a dispute party referring to the specific argument. This was mainly the case in the context of determining the scope of property rights and the existence of an expropriation. As all U.N. member states have human rights obligations, international investment laws must be presumed to be in conformity with the relevant human rights obligations.

• 인터넷정보학회지
• /
• 제14권3호
• /
• pp.52-57
• /
• 2013

Information and Communication Technologies(ICTs) have substantially enlarged both the opportunities to realize one's human rights but have also resulted in the emergence of new challenges. ICTs are so deeply embedded and cental to almost all aspects of human activity. And ICTs are assuming an increasingly central role in all aspects of human and societal development across the world. But this is especially true of the right to privacy, which faces challenges such as profiling and data mining for public(including national security) and private purposes. ICTs access is a fundamental right for all humans in the information age. So we have need for regulation based on human rights in the digital age. And governments have a responsibility to protect individuals against violations of human rights and data protection by public authorities, but also by private entities. In addition, internet governance and multi-stakeholder principle have to be stressed on all of the internet issues because internet governance is included in the principle of democracy which have bottom-up communication and equality. So it is very importance that Internet Governance Forum is the space for a meaningful discussion on public policy issues relating to the internet.

• 한국원자력학회:학술대회논문집
• /
• 한국원자력학회 2003년도 춘계학술발표대회 요약집
• /
• pp.95-95
• /
• 2003

• 한국항해항만학회지
• /
• 제43권6호
• /
• pp.395-402
• /
• 2019

최근 보다 안전하고 효율적인 해상운송시스템을 위한 해결책으로 자율운항선박의 개발 및 운용에 대한 논의가 활발히 진행되고 있다. 자율운항기술은 해양사고 방지, 선박의 연비 증진, 비용 절감 등 긍정적인 측면과 함께 선원의 일자리 감소, 업무의 변화, 보안문제 등 부정적인 측면도 상존하고 있다. 향후 자율운항선박의 시대가 도래 하더라도 육상 센터에서의 제어가 이루어지게 되므로, 육상 운항사의 상황인식과 같이 새로운 인적요인 이슈가 존재할 것으로 예측된다. 본 논문에서는 자율운항선박의 개발 및 운용과정에 고려해야 할 주요 인적요인 이슈를 고찰하고, 육상 센터의 제어에 따라 예상되는 육상 운항사의 의사결정 및 업무수행에 영향을 미치는 요소에 대한 식별과 영향 요소의 평가를 위한 인적 신뢰성 분석 방안을 제시하였다.

• 보건행정학회지
• /
• 제14권3호
• /
• pp.97-121
• /
• 2004

Recently, human embryonic stem cell research raises exciting public expectation on medical possibilities as well as ethical debate. Embryo management has become an integral part of the management of infertility treatment, researches on embryo and human embryonic stem cells and so on. Britain has permitted the research on stem cells derived from human embryo which made the first nation to allow the cloning of human embryo for the stem cell research. However, new technologies such as the assisted reproductive technologies and human embryonic stem cell research continue to pose an increasing source of ethical dilemmas for physician, scientists, legislators, religious authorities and the general publics to deal with. None the less, the United Kingdom has adopted the most liberal policies regarding human embryo and human embryonic stem cell research. The implication of the British embryo management system are as follows: 1) the development of reproductive technologies and new stem cell research technologies continue to pose legal and ethical debates, since those involve several parties; 2) the UK has taken the legal and institutional approaches to cope with those serious issues; 3) the UK adopted most liberal policies regarding embryonic and human embryonic stem cell researches; 4) the British HFE Act is consistent with the existing Acts related to human embryo management and researches; 5) through amending the HFE Act to accomodate the changes of technologies, the UK try to minimize the legal and ethical burden on undertaking research regarding embryo. The debates about the researches on human embryo and human embryonic stem cells is likely to continue in the Korean society. Because of the controversy and competing ethical values, as well as the evolving technologies, so far no consensus exists in our society. It suggest that it is premature to bring closure by ruling out any particular approaches. Thus our society needs to make an efforts to find a basis which could resolve the societal controversies through enriching the societal conversation about the profound ethical issues regarding embryo management.

• 제어로봇시스템학회논문지
• /
• 제13권1호
• /
• pp.65-71
• /
• 2007

Adjustable autonomy architecture provides various ways for a human operator to participate as a member of a human-robot team in improving the performance of the team by resolving issues that the robots cannot deal with or performing tasks that the robots alone would unable to do. According to the level of involvement of the human operator, the robots have to adjust their level of autonomy and, in consequence, the operation mode of the overall system shifts. This paper deals with the implementation issues of seamless switching when the level of autonomy of the human-robot team shifts from one level to another. Especially, we focus on developing reliable methods for monitoring the task progress and maximizing the system flexibility by coping with the detailed differences between humans and robots in their characteristics of motions and their choices of positions, paths, and sequences of sub-goals to achieve a given task. To test and motivate the proposed methods, we have assembled three heterogeneous robots which work together to dock both ends of a suspended beam into stanchions.

• 해양환경안전학회지
• /
• 제25권5호
• /
• pp.560-571
• /
• 2019

유엔의 제1차 및 2차 세계인권프로그램 행동계획에 따라 세계 개별 국가들은 자발적 참여와 법제도의 정비를 통하여 인권교육의 강화와 발전을 위하여 노력하고 있다. 이러한 시대적 상황변화에 따라 우리나라는 인권위원회를 중심으로 인권교육을 확산하려고 노력하고 있으나, 큰 진전이 없고 더욱이 승선 중인 선원인권에 대해서는 제대로 된 관심을 기울이지 못하고 있다. 따라서 이 연구는 혼승선박에 승선하고 있는 선원들의 인권강화를 위한 교육환경을 조성하기 위하여 이와 관련된 국내외 각종 문헌자료와 선원인권침해 사례를 바탕으로 현상학적인 문제를 인식하고 상호주관적인 연구방법을 활용하였다. 이를 통하여 최근 혼승선박에서 발생하는 갈등의 핵심 원인으로 지목되고 있는 선원인권에 대한 근원적인 해결책으로 선원인권교육의 도입 필요성과 지정교육기관의 인권교육과정에 대한 방안을 제시하였다.

• 인지과학
• /
• 제29권1호
• /
• pp.61-84
• /
• 2018

본 논문은 신경윤리의 철학적 의미와 인지 패러다임 안에서의 독자적 위치를 검토하고, 신경윤리의 쟁점들을 고찰하는 것을 목적으로 한다. 뇌과학의 발전은 인간 정신에 대한 보다 직접적인 탐구와 개입을 가능하게 하여 전통적인 물질과 정신의 경계를 약화시키고, 인간 본성에 대한 새로운 철학적 질문들을 제기한다. 신경윤리는 기존 법적, 사회적 체계에서 포괄하기 어려운 뇌과학과 관련된 윤리적 문제들을 다루기 위하여 학제적이고 통합적 관점을 취한다. 신경윤리의 쟁점들 중에는 일부 고전적 생명윤리 쟁점과 겹치는 부분도 있지만 뇌과학과의 관련성 안에서만 특수하게 발견할 수 있는 문제들이 더 많다. 신경윤리의 고유 쟁점은 대체로 두뇌활동의 관찰과 복호화를 통한 마음읽기와 두뇌활동에 대한 개입을 통한 인지향상과 관련되어 있는데, 이러한 문제들을 다루기 위해서는 생명윤리 하위 분야를 넘어서는 독자적 분야로서의 신경 윤리가 필요하다는 주장도 제기되고 있다. 최근 뇌과학 연구 동향과 발전 단계를 고려할 때, 국내에서도 본격적인 신경윤리 논의와 관련 분야 전문가들의 협력을 시작할 필요가 있다.

• 공학교육연구
• /
• 제18권2호
• /
• pp.33-42
• /
• 2015

The shortage of R&D personnel and the lower productivity of SMEs are critical issues in strengthening SMEs. Government provides various policies to deal with these issues. The aim of this paper is to analyze current status and policy issues of R&D personnel and to suggest policy alternatives to improve the availability of R&D personnel in SMEs.